The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
107401715 10740171 5 F 20141103 20160628 20150127 20160701 EXP CN-009507513-1412CHN001993 MERCK 51.00 YR F Y 55.00000 KG 20160701 MD CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
107401715 10740171 1 PS EMEND APREPITANT 1 Oral 125 MG, ONCE, DAY 1 Y1248 21549 125 MG CAPSULE 1X
107401715 10740171 2 SS EMEND APREPITANT 1 Oral 80 MG, ONCE, DAY 2 Y1248 21549 80 MG CAPSULE 1X
107401715 10740171 3 SS EMEND APREPITANT 1 Oral 80 MG, ONCE, DAY 3 Y1248 21549 80 MG CAPSULE 1X
107401715 10740171 4 C EPIRUBICIN HYDROCHLORIDE. EPIRUBICIN HYDROCHLORIDE 1 Intravenous drip 140 MG, ONCE, TREATMENT CYCLE 2 U 0 140 MG INJECTION 1X
107401715 10740171 5 C CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 0.8 G/D 1, ONCE, TREATMENT CYCLE 2 U 0 .8 G INJECTION 1X
107401715 10740171 6 C FLUOROURACIL. FLUOROURACIL 1 Intravenous drip 0.75 G/D1, ONCE, TREATMENT CYCLE 2 1 G U 0 .75 G INJECTION 1X
107401715 10740171 7 C PALONOSETRON HYDROCHLORIDE. PALONOSETRON HYDROCHLORIDE 1 Intravenous drip 0.25 MG, ST U 0 .25 MG INJECTION
107401715 10740171 8 C PALONOSETRON HYDROCHLORIDE. PALONOSETRON HYDROCHLORIDE 1 Intravenous drip 0.25 MG, ONCE U 0 .25 MG INJECTION 1X
107401715 10740171 9 C PHENERGAN PROMETHAZINE HYDROCHLORIDE 1 Intramuscular TOTAL DAILY DOSE: 12.5 MG, ST U 0 12.5 MG INJECTION QD
107401715 10740171 10 C OMEPRAZOLE. OMEPRAZOLE 1 Intravenous (not otherwise specified) 40 MG, ST U 0 40 MG INJECTION
107401715 10740171 11 C OMEPRAZOLE. OMEPRAZOLE 1 Intravenous (not otherwise specified) 40 MG, ONCE U 0 40 MG INJECTION 1X
107401715 10740171 12 C DEXAMETHASONE. DEXAMETHASONE 1 Intravenous drip 20 MG, ONCE U 0 20 MG INJECTION 1X

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
107401715 10740171 1 Prophylaxis of nausea and vomiting
107401715 10740171 4 Chemotherapy
107401715 10740171 5 Chemotherapy
107401715 10740171 6 Chemotherapy
107401715 10740171 7 Prophylaxis of nausea and vomiting
107401715 10740171 9 Prophylaxis of nausea and vomiting
107401715 10740171 10 Prophylaxis
107401715 10740171 12 Prophylaxis of nausea and vomiting

Outcome of event

Event ID CASEID OUTC COD
107401715 10740171 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
107401715 10740171 Bone marrow failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
107401715 10740171 1 20141030 20141030 0
107401715 10740171 2 20141031 20141031 0
107401715 10740171 3 20141101 20141101 0
107401715 10740171 4 20141030 20141030 0
107401715 10740171 5 20141030 20141030 0
107401715 10740171 6 20141030 20141030 0
107401715 10740171 7 20141030 20141030 0
107401715 10740171 8 20141120 20141120 0
107401715 10740171 9 20141030 20141030 0
107401715 10740171 10 20141030 20141030 0
107401715 10740171 11 20141120 20141120 0
107401715 10740171 12 20141030 20141030 0